Interleukin 2- and interleukin 5-induced changes in the binding of regulatory factors to the J-chain gene promoter

Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11027-31. doi: 10.1073/pnas.88.24.11027.

Abstract

In a primary immune response, B cells require signals from the T-cell lymphokines interleukins 2 and 5 (IL-2 and IL-5) to develop into IgM-secreting cells. One role of IL-2 and IL-5 is to activate transcription of the gene encoding the IgM joining component, the J chain. In this study the activation mechanism was investigated by using an inducible beta-lymphoma cell line to examine J-chain RNA expression and factor binding to the J-chain promoter. The analyses revealed that both IL-2 and IL-5 trigger a decrease in the binding of two promoter-specific nuclear proteins that precedes the appearance of J-chain RNA. In combination the two lymphokines effected nearly additive changes in factor binding and J-chain RNA abundance. Both effects were reversed upon withdrawal of the lymphokine stimulus and both were inhibited in the presence of the T-cell lymphokine IL-4. These findings indicate that the IL-2 and IL-5 signal pathways converge to deliver a common signal that regulates the repressor activities of two lymphokine-responsive promoter elements.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Binding Sites
  • Cell Line
  • Cell Nucleus / physiology
  • Genes, Immunoglobulin*
  • Humans
  • Immunoglobulin J-Chains / genetics*
  • Immunoglobulin M / genetics*
  • Interleukin-2 / pharmacology*
  • Interleukin-5 / pharmacology*
  • Lymphoma, B-Cell
  • Mice
  • Nuclear Proteins / metabolism*
  • Promoter Regions, Genetic* / drug effects
  • Recombinant Proteins / pharmacology
  • Restriction Mapping
  • TATA Box
  • Transcription, Genetic / drug effects

Substances

  • Immunoglobulin J-Chains
  • Immunoglobulin M
  • Interleukin-2
  • Interleukin-5
  • Nuclear Proteins
  • Recombinant Proteins